REGENXBIO, Inc. (RGNX)
10.33
+0.07
(+0.68%)
USD |
NASDAQ |
Feb 06, 16:00
10.30
-0.03
(-0.29%)
After-Hours: 20:00
REGENXBIO Cash and Short Term Investments (Quarterly) : 274.20M for Sept. 30, 2025
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Omeros Corp. | 36.08M |
| Sarepta Therapeutics, Inc. | 850.99M |
| AbbVie, Inc. | -- |
| CytomX Therapeutics, Inc. | 143.63M |
| Krystal Biotech, Inc. | 731.07M |